A Study to Assess the Accuracy of Magnetocardiography (MCG) to Diagnose True Ischemia in Patients With Chest Pain in the ED
(MCG Trial)
Recruiting in Palo Alto (17 mi)
SH
Overseen bySara Hevesi, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Mayo Clinic
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of the research is to see if patients that come to the Emergency Department with chest pain can be more accurately and more quickly diagnosed by magnetocardiography (MCG) to see if their chest pain is caused by coronary ischemia (reduced blood flow to the heart) in patients with normal or have non-specific changes on the ECG vs other causes by other reasons.
Research Team
SH
Sara Hevesi, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
Patients presenting to the ED with acute chest pain when an ACS is on the differential diagnosis.
Patient willing and able to give informed consent.
Treatment Details
Interventions
- Magnetocardiography (MCG) (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Trials
3,427
Recruited
3,221,000+
Dr. Gianrico Farrugia
Mayo Clinic
Chief Executive Officer since 2019
MD from University of Malta Medical School
Dr. Richard Afable
Mayo Clinic
Chief Medical Officer
MD from Loyola Stritch School of Medicine